Possible role of citalopram and desipramine against sleep deprivation-induced anxiety like-behavior alterations and oxidative damage in mice.
Sleep is an essential physiological process for maintaining physical, mental, and emotional health. Sleep deprivation and associated disorders like depression and anxiety are one of the major problems now-days. The present study was designed to explore the neuroprotecitve effect of citalopram and desipramine on 72 hr sleep deprivation-induced behavioral alterations and oxidative damage in mice. Various behavioral tests (plus maze, zero maze, mirror chamber, actophotometer), body weight followed by oxidative parameters (malondialdehyde level, glutathione, catalase, nitrite and protein) were assessed. Treatment with citalopram (5 and 10 mg/kg, ip) and desipramine (10 and 20 mg/kg, ip) for 5 days significantly improved locomotor activity, anti-anxiety like behavior in all paradigms tasks (mirror chamber, plus maze, zero maze) as compared to control (72 hr sleep-deprived). Biochemically, citalopram and desipramine treatment significantly restored depleted reduced glutathione, catalase activity, attenuated raised lipid peroxidation and nitrite level as compared to control (72 hr sleep-deprived) animals. Results of present study suggest that citalopram (5 and 10mg/kg, ip) and desipramine (10 and 20 mg/kg, ip) have neuroprotective effect against sleep deprivation-induced behavior alteration and oxidative damage in mice.
Garg
Ruchika
R
Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160 014, India.
Kumar
Anil
A
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000818:Animals; D001007:Anxiety; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D015283:Citalopram / Q000494:pharmacology*; D003891:Desipramine / Q000494:pharmacology*; D018782:Maze Learning; D051379:Mice; D009068:Movement; D018696:Neuroprotective Agents / Q000494:pharmacology; D018384:Oxidative Stress; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects; D012892:Sleep Deprivation / Q000188:drug therapy*
D018759:Adrenergic Uptake Inhibitors; D015283:Citalopram; D003891:Desipramine; D018696:Neuroprotective Agents; D017367:Selective Serotonin Reuptake Inhibitors